Apple iPhone 17 Will Premiere Major Design Upgrade, New Report Hints
When the iPhone 17 series lands, it's going to look very different from the current line-up. And a new report tells us exactly how big the displays will be —and seems to confirm a highly desirable upgrade is coming.
Apple iPhone 16: will the iPhone 17 have a ProMotion screen for the first time?
While the iPhone 17 Pro and iPhone 17 Pro Max will stick with the display sizes Apple introduced last year for the Pro models, the regular iPhone 17 will gain a bigger, and possibly better, screen.
According to Ross Young, an analyst who specializes in displays, in a post on X for subscribers only, and picked up by MacRumors, the display sizes will be changing.
Apple iPhone 17 screen will be bigger than the iPhone 16 display by 0.15 inches, that is, it'll go up from 6.12 inches to 6.27 inches, which will match the size of the iPhone 16 Pro screen.
Apple rounds these figures, describing the iPhone 16 as having a 6.1-inch display, and the iPhone 16 Pro screen as measuring 6.3 inches. Expect the same this September.
Young says that the iPhone 17 Pro will continue to have the same size screen as it does now, that is, 6.27 inches.
Which makes me think that Apple may be about to release the first regular iPhone with ProMotion, the advanced dynamic refresh rate until now exclusively on iPhone's Pro models. After all, the screen size increase to match the Pro means Apple could use the same display on both models. ProMotion also enables the always-on display on the Pro, so this could be coming to the regular iPhone, too.
The iPhone 17 Pro display is thought to be the same as now, that is 6.86 inches (6.9 inches in Apple Speak). Finally, the new slimmer phone, nicknamed iPhone 17 Air, will have a 6.55-inch display, Ross claims.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
13 minutes ago
- Medscape
Same-Day Discharge Criteria Outlined for AF Ablation
SAN DIEGO — Same-day discharge after ablation of atrial fibrillation (AF) is an appropriate strategy for saving costs if performed with strict selection criteria and protocols, according to a recently issued joint statement from the American College of Cardiology and the Heart Rhythm Society. Same-day discharge has long been indicated for catheter ablations to abort routine atrial flutter, atrioventricular nodal reentrant tachycardia, and focal atrial tachycardias, according to the authors of the new joint statement. Although they maintained patients selected for elective catheter ablation of AF require heightened scrutiny, they endorsed same-day AF ablation when used selectively. The statement evaluates 'evidence supporting shorter hospitalization stay with same-day discharge for intracardiac ablations agonistic to site of care,' reported Amit J. Shankar, MD , an electrophysiologist with Canton-Potsdam Hospital in Potsdam, New York, who served as a representative for the Heart Rhythm Society in developing the statement. Whether in a hospital setting or an outpatient facility, the statement describes same-day discharge ablation as an opportunity to improve patient access, improve efficiency, and reduce healthcare costs. The adoption of same-day discharge after AF ablation was accelerated during the COVID-19 pandemic, said Samuel O. Jones, MD, a cardiologist affiliated with The Chattanooga Heart Institute in Chattanooga, Tennessee, and a fellow of the American College of Cardiology. 'Improved workflows, technological innovations, and procedure advancements have also contributed to the high rates at which these are performed,' added Jones, who helped write the statement. The statement was released on April 24 to coincide with the first day of the Heart Rhythm Society (HRS) 2025 annual scientific meeting. It was simultaneously published in Heart Rhythm and the Journal of the American College of Cardiology . The scientific statement's recommendation is intended for elective rather than urgent or emergency ablations. Support for the statement was drawn from multiple case-controlled studies, meta-analyses, and outcome databases. In one example, a 12-study meta-analysis with data from more than 18,000 elective ablations showed no significant differences in major complications from the procedure among the 40.5% of patients discharged the same day relative to those who were discharged after at least one night in the hospital. In another study, drawn from a real-world prospective registry, outcomes were compared for potential candidates for same-day ablation on the basis of prespecified criteria and those who were not eligible for the procedure. These criteria included no bleeding history, a left ventricular ejection fraction greater than 40%, no pulmonary disease, and no surgical procedures within the previous 60 days. Of the 2332 patients included in the analysis, 1982 (85%) were deemed candidates for same-day ablation. Although freedom for atrial arrhythmias was comparable ( P = .0212) for the two groups, patients discharged the same day had a lower rate of complications (0.8% vs 2.9%; P < .001). The rate of readmission was similar (0.8% vs 09%; P = .924), according to the researchers. Contraindications for Same-Day Ablation In the document, relative contraindications for same-day ablation include decompensated heart failure, significant pulmonary disease, significant risk of bleeding, and any major unstable comorbidities such as diabetes, hypertension, or renal disease. The document recommends limiting same-day procedures to patients who can have readily available social support and can return to a hospital quickly in the event of a post-procedural complication. Acknowledging that most large hospitals offering ablation for AF already have formal selection criteria and protocols in place for same-day discharge, the authors called for free-standing sites to establish their own if they have not done so. In these settings, the authors emphasized the need to rigorously follow prespecified and 'ironclad' selection criteria and protocols. From this standpoint, Shankar said same-day procedures should always be performed on the basis of shared decision-making with the patient. While the economic benefits of same-day procedures might be shared by the facility and the patient, the latter should understand the inherent differences in the settings and participate actively in any decision of where the ablation is performed. Jones said while a substantial body of evidence supports same-day AF ablation as a safe and effective procedure that can free up necessary resources in the healthcare facility, the potential advantages are relevant only to appropriately selected patients. The new statement also suggests transfer agreements with inpatient facilities should be arranged in advance and that patients should be informed such a transfer is a possibility outside of a hospital setting. However, the document makes clear same-day ablations in alternative sites of care are reasonable when the precautions are observed. In any setting that AF ablation is performed, the writing committee encouraged tracking outcomes to ensure that high-quality care is achieved and sustained. Shankar and Jones reported no potential conflicts of interest.
Associated Press
19 minutes ago
- Associated Press
Cano, Little Rock beat No. 6 national seed LSU 10-4, force decisive game Monday in Baton Rouge
BATON ROUGE, La. (AP) — Angel Cano hit a two-run home run in the second inning and a bases-clearing double in the third to help No. 4 seed Little Rock beat host and top-seeded LSU 10-4 on Saturday night to win avoid elimination at the Baton Rouge Regional on Sunday night. The Trojans (27-33), making their second NCAA Tournament appearance and first since 2014, can clinch a berth in the super regionals with a win Monday over No. 6 national seed LSU. LSU beat Little Rock 7-0 on Friday and followed Saturday with a 12-0 win over Dallas Baptist to advance to the championship round. The Trojans, who lost 13 of 14 to close the regular season before winning five straight to win the Ohio Valley Conference Tournament, exploded for 22 runs Saturday in a win over Rhode Island and beat Dallas Baptist 8-6 in an elimination game earlier Sunday. Steven Milam hit a two-RBI single to cap LSU's three run first inning but Angel Cano hit a two-run home run in the second for the Trojans. Ryan Geck grounded out to lead off the third before Ty Rhoades, Cade Martin and Cooper Chaplain drew consecutive walks to load the bases. Cano fouled off three consecutive two-strike pitches before he hit a bases-clearing double off Chase Shores (5-3), who was immediately replaced by Cooper Williams after allowing four runs in an inning of relief. Starter Noah Burkey gave up three runs on six hits in 1 2/3 innings before he was replaced by Brenden Katz (1-0), who pitched 1 2/3 scoreless innings. Malcolm Brown threw 5 1/3 innings and gave up a run on three hits to earn his first save of the season. ___ AP sports:
Screen Geek
20 minutes ago
- Screen Geek
Ethan Hawke Returns In First Trailer For 'Black Phone 2'
The 2021 horror movie The Black Phone became a surprise horror hit for Blumhouse based on the short story of the same name by author Joe Hill. Because the film was such a hit, earning $161.4 million on a budget between $16-18 million, a sequel was greenlit several years later. Now the full trailer for the follow-up – titled Black Phone 2 – has been released by Universal. Interestingly, the new sequel revolves around the characters from the first film, with the roles having been aged up to reflect the increased age of the actors. Ethan Hawke also returns to play The Grabber, the brutal antagonist of the first film, which this trailer depicts in a more Freddy Krueger style fashion. Here's the official trailer for Black Phone 2 : This trailer for Black Phone 2 puts an emphasis on the tense atmosphere that the film will feature, with an emphasis on its snowy winter setting, something which is a change from the original. Likewise, the footage is grainy and dark, with the signature use of filmic imagery that is enough to make viewers' blood run as cold as the wintery shots depicted. The cast for Black Phone 2 , as the trailer features, includes returning cast members Ethan Hawke, Mason Thames, Madeleine McGraw, Jeremy Davies and Miguel Mora. For Hawke's character, given his fate in the preceding flick, it looks like his role as The Grabber has expanded into a more supernatural threat. Scott Derrickson returned to direct the follow-up for Blumhouse and Universal which was once again written by C. Robert Cargill and Derrickson. The two seem to have cracked a great idea that made producing a sequel a worthwhile endeavor. Black Phone 2 is scheduled to hit theaters later this year on October 17, 2025. Stay tuned to ScreenGeek for any additional updates regarding this highly-anticipated sequel to the horror hit The Black Phone as we have them.
